PROTOPAM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Protopam Chloride, and when can generic versions of Protopam Chloride launch?
Protopam Chloride is a drug marketed by Baxter Hlthcare Corp and Wyeth Ayerst and is included in two NDAs.
The generic ingredient in PROTOPAM CHLORIDE is pralidoxime chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralidoxime chloride profile page.
Summary for PROTOPAM CHLORIDE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 504 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PROTOPAM CHLORIDE |
| What excipients (inactive ingredients) are in PROTOPAM CHLORIDE? | PROTOPAM CHLORIDE excipients list |
| DailyMed Link: | PROTOPAM CHLORIDE at DailyMed |
Pharmacology for PROTOPAM CHLORIDE
| Drug Class | Cholinesterase Reactivator |
| Mechanism of Action | Cholinesterase Reactivators |
Anatomical Therapeutic Chemical (ATC) Classes for PROTOPAM CHLORIDE
US Patents and Regulatory Information for PROTOPAM CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | PROTOPAM CHLORIDE | pralidoxime chloride | INJECTABLE;INJECTION | 014134-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Wyeth Ayerst | PROTOPAM CHLORIDE | pralidoxime chloride | TABLET;ORAL | 014122-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
